JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BORR
4276
Borr Drilling
BORR
$1.28B
| $133K | ﹤0.01% |
+59,572
| New | +$112K |
2020 Q2
0 quarters
|
|
4277
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$379M
| $133K | ﹤0.01% |
+3,853
| New | +$130K |
2020 Q2
0 quarters
|
|
|
ALSK
4278
DELISTED
Alaska Communications Systems
ALSK
| $133K | ﹤0.01% |
47,661
+6,945
| +17% | +$15.8K |
2020 Q1
1 quarter
|
|
4279
Escalade
ESCA
$262M
| $132K | ﹤0.01% |
9,479
-6,293
| -40% | -$58.3K |
2017 Q4
10 quarters
|
|
4280
PUT
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.5B
| $132K | ﹤0.01% |
+800
| New | +$121K |
2020 Q2
0 quarters
|
|
4281
Spyre Therapeutics
SYRE
$8.18B
| $131K | ﹤0.01% |
565
-743
| -57% | -$142K |
2017 Q2
12 quarters
|
|
|
FAZ
4282
Direxion Daily Financial Bear 3x ETF
FAZ
$93.7M
| $130K | ﹤0.01% |
92
+86
| +1,433% | +$163K |
2018 Q4
6 quarters
|
|
4283
Genasys
GNSS
$65.1M
| $130K | ﹤0.01% |
+26,726
| New | +$118K |
2020 Q2
0 quarters
|
|
4284
Norwood Financial Corp
NWFL
$368M
| $130K | ﹤0.01% |
5,251
-4,922
| -48% | -$117K |
2017 Q4
10 quarters
|
|
4285
Regis Corp
RGS
$73.2M
| $130K | ﹤0.01% |
793
-288
| -27% | -$54K |
2013 Q2
28 quarters
|
|
|
HARP
4286
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $130K | ﹤0.01% |
787
+552
| +235% | +$86.1K |
2019 Q1
5 quarters
|
|
|
TEN
4287
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $130K | ﹤0.01% |
17,180
+511
| +3% | +$2.98K |
2013 Q2
28 quarters
|
|
|
NE
4288
DELISTED
Noble Corporation
NE
| $130K | ﹤0.01% |
405,090
-10,551
| -3% | -$2.71K |
2013 Q2
28 quarters
|
|
|
BDSI
4289
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $130K | ﹤0.01% |
29,904
+2,496
| +9% | +$11.2K |
2018 Q2
8 quarters
|
|
4290
Auburn National Bancorp
AUBN
$91.8M
| $128K | ﹤0.01% |
2,241
+2,141
| +2,141% | +$106K |
2018 Q1
9 quarters
|
|
4291
OneWater Marine
ONEW
$161M
| $128K | ﹤0.01% |
5,311
-3,667
| -41% | -$51.8K |
2020 Q1
1 quarter
|
|
4292
Ducommun
DCO
$2.61B
| $126K | ﹤0.01% |
3,637
+61
| +2% | +$1.8K |
2017 Q4
10 quarters
|
|
4293
MannKind Corp
MNKD
$1.23B
| $126K | ﹤0.01% |
72,078
+10,007
| +16% | +$14K |
2016 Q4
14 quarters
|
|
4294
Richmond Mutual Bancorp
RMBI
$246M
| $126K | ﹤0.01% |
11,261
-10,004
| -47% | -$106K |
2019 Q3
3 quarters
|
|
|
SREV
4295
DELISTED
ServiceSource International, Inc.
SREV
| $126K | ﹤0.01% |
+79,762
| New | +$109K |
2020 Q2
0 quarters
|
|
4296
Champions Oncology
CSBR
$69.2M
| $125K | ﹤0.01% |
13,073
+10,820
| +480% | +$92.2K |
2020 Q1
1 quarter
|
|
4297
Passage Bio
PASG
$13.2M
| $125K | ﹤0.01% |
+229
| New | +$103K |
2020 Q2
0 quarters
|
|
|
MORF
4298
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $125K | ﹤0.01% |
4,618
-3,843
| -45% | -$71.9K |
2019 Q3
3 quarters
|
|
4299
Schwab Fundamental US Small Company Index ETF
FNDA
$8.83B
| $124K | ﹤0.01% |
7,788
+5,428
| +230% | +$80.3K |
2018 Q2
8 quarters
|
|
|
ZYXI
4300
PUT
DELISTED
Zynex
ZYXI
| $124K | ﹤0.01% |
+5,500
| New | +$92.1K |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.